Position in JNJ
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$8,629,646
+$358,775 QoQ
Shares Held
33,979
+0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.94%
of 13F equity value
Holder Rank
#1,201
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Monte Financial Group, LLC holds $28,595,491 across 7 Drug Manufacturers - General names. JNJ ranks #1 (30.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
33,979 | $8,629,646 | |
| 2 | NVS |
Novartis AG
|
44,535 | $6,979,525 | |
| 3 | MRK |
Merck & Co., Inc.
|
51,508 | $6,618,778 | |
| 4 | PFE |
Pfizer Inc
|
173,412 | $4,175,760 | |
| 5 | AZN |
Astrazeneca PLC
|
9,226 | $1,749,434 | |
| 6 | NVO |
Novo Nordisk A S
|
4,982 | $238,837 | |
| 7 | AMGN |
Amgen Inc
|
562 | $203,511 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,629,646 | 33,979 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $8,270,871 | 33,836 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $7,300,575 | 35,277 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $6,839,216 | 36,885 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $5,604,703 | 36,692 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $6,075,714 | 36,636 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $5,231,194 | 36,172 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $5,809,526 | 35,848 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $5,255,475 | 35,957 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $4,781,450 | 30,226 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $4,702,043 | 29,999 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $5,161,710 | 33,141 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $5,302,267 | 32,034 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $4,934,890 | 31,838 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $5,677,177 | 32,138 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $5,232,910 | 32,033 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $5,594,405 | 31,516 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $5,542,868 | 31,275 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $5,282,128 | 30,877 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $4,790,090 | 29,660 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $4,411,901 | 26,781 | Shares | Sole | 2021-10-25 | |
| 2021-03-31 | $3,820,315 | 23,245 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $3,691,820 | 23,458 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $3,499,275 | 23,504 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $3,482,842 | 24,766 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $3,287,297 | 25,069 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||